SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-13-000044
Filing Date
2013-08-09
Accepted
2013-08-09 13:11:45
Documents
2
Period of Report
2013-08-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 GENESIS BIOPHARMA CURRENT REPORT currentreport.htm 8-K 23156
2 PRESS RELEASE DATED AUGUST 8, 2013 ex991.htm EX-99.1 19199
  Complete submission text file 0001513160-13-000044.txt   43565
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 131025621
SIC: 4731 Arrangement of Transportation of Freight & Cargo